Adalimumab and rheumatoid arthritis Archives

Abstract Number: 2470 • ACR/ARHP Annual Meeting 2014
Treatment Strategy for Maximizating the Effect of Adalimumab in Japanese Patients with Rheumatoid Arthritis : Retrospective Analyses of Data Collected from the Patient Treated with Adalimumab in Routine Clinical Practice in Hamamatsu Area
Toshiaki Miyamoto, Rheumatology, SEIREI HAMAMATSU GENERAL HOSPITAL, Hamamatsu, Japan
Background/Purpose: Adalimumab (ADA) showed highly efficacious in rheumatoid arthritis (RA) in the clinical trials, although there is little evidence in daily clinical practice.The clinical usefulness…
Abstract Number: 776 • ACR/ARHP Annual Meeting 2012
A Multicenter, Randomized, Controlled, Open-Label Pilot Study of the Feasibility of Discontinuation of Adalimumab in Rheumatoid Arthritis Patients in Stable Clinical Remission
Katerina Chatzidionysiou¹, Carl Turesson², Annika Teleman³, Ann Knight⁴, Elisabet Lindqvist⁵, Per Larsson⁶, Lars Cöster⁷, Barbro Rydberg⁸, Ronald F. van Vollenhoven⁹ and Mikael Heimbürger¹⁰, ¹Dept of Medicine, Unit for Clinical Research Therapy. Inflammatory Diseases (ClinTrid), Karolinska Institute, Stockholm, Sweden, ²Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ³Department of Rheumatology, Spenshult Hospital, Oskarstrom, Sweden, ⁴Dept of Rheumatology, Institution for Medical Sciences, Uppsala University, Uppsala, Sweden, ⁵Department of Clinical Sciences, Section for Rheumatology Lund University, Lund, Sweden, ⁶Dept of Rheumatology, Karolinska University Hospital, Stockholm, Sweden, ⁷Department of Rheumatology, University Hospital, Linköping, Sweden, ⁸Department of Rheumatology, Kärnsjukhuset, Skövde, Sweden, ⁹Unit for Clinical Trial Therapy research, The Karolinska Institute, Stockholm, Sweden, ¹⁰Medical department, Abbott Scandinavia, Stockholm, Sweden
Background/Purpose: Treatment with TNF blockers, once started as therapy for RA, is usually continued indefinitely. Information about the possibility to discontinue anti-TNF therapy in RA…

Abstracts tagged "Adalimumab and rheumatoid arthritis"

Treatment Strategy for Maximizating the Effect of Adalimumab in Japanese Patients with Rheumatoid Arthritis : Retrospective Analyses of Data Collected from the Patient Treated with Adalimumab in Routine Clinical Practice in Hamamatsu Area

A Multicenter, Randomized, Controlled, Open-Label Pilot Study of the Feasibility of Discontinuation of Adalimumab in Rheumatoid Arthritis Patients in Stable Clinical Remission